As a sponsor of the USC Viterbi School of Engineering and a provider of energy solutions to medical facilities, Regatta Solutions is pleased to spread the news about this important presentation on Alzheimer’s.

OC Speaker Series: An Evening with Roberta Brinton, April 22nd
“Have you lost your keys recently? Been unable to remember the name of a close friend or family member? Forgot how to do everyday tasks? Learn how to distinguish between normal aging and the early onset of Alzheimer’s and why there is Hope on the Horizon as we continue our 2015 Orange County Distinguished Speaker Series.
World-renowned researcher, Dr. Roberta Diaz Brinton, the director of the USC Science, Technology and Research Program (STAR) science-education outreach program, is the foremost authority on current advances in the fight against this devastating disease.
Hear about the current state of Dr. Brinton’s groundbreaking research and the broader fight against Alzheimer’s in this intimate evening in Orange County.
Light dinner and refreshments will be served!
Full details and registration
Roberta Diaz Brinton, PhD, professor of Pharmacology and Pharmaceutical Sciences in the University of Southern California (USC) School of Pharmacy, where she holds the R. Pete Vanderveen Chair in Therapeutic Discovery and Development. Brinton is also professor of Biomedical Engineering in the USC Viterbi School of Engineering and professor of Neurology in the Keck School of Medicine of USC. Brinton was named one of the “Ten Best Minds” by U.S. News and World Report, “Woman of the Year” by the California State Senate, and “Science Educator of the Year” by the Society for Neuroscience. Brinton received the Presidential Citizens Medal for her decades of commitment to science education through the USC Science, Technology and Research STAR Program. She also developed and directed Preclinical Translation and Regulatory Support Program at the USC Clinical and Translational Science Institute. Brinton leads the Norris Foundation Laboratory for Neuroscience Research, where her science spans discovery, translational and clinical research in Alzheimer’s disease. Her team focuses on the mechanisms underlying risk of Alzheimer’s disease and the development of therapeutic strategies to prevent, delay and treat the disease. Her discovery and translational research has led to two National Institute on Aging clinical trials, one to prevent Alzheimer’s disease and another to treat early stages of the disease by promoting endogenous regeneration of the brain.